NASDAQ · Healthcare · Biotechnology
Altimmune, Inc.
ALT
Altimmune, Inc. CEO Jerome Benedict Durso · Market cap $604.8M.
$3.11
+0.16 · +5.42%
52w hi $6.4452w lo $2.56
Off 52w high 55.3%
66
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
6
0 strong · 6 notable
Analyst consensus
Strong Buy
Avg PT $6.25
Section 01
Recent Form 4 filings
7 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 13 | Jerome Benedict Durso | President and CEO | Buy | 15,000 | $2.95 | +$44K | 66 |
| Apr 06 | John Gill | Buy | 9,200 | $3.41 | +$31K | 58 | |
| Apr 01 | Jerome Benedict Durso | President and CEO | Buy | 15,000 | $3.14 | +$47K | 74 |
| Apr 01 | Gregory L Weaver | Chief Financial Officer | Buy | 10,000 | $3.15 | +$31K | 71 |
| Mar 06 | Jerome Benedict Durso | President and CEO | Buy | 20,000 | $3.54 | +$71K | 69 |
| Dec 23 | John Gill | Buy | 12,500 | $4.10 | +$51K | 60 | |
| Dec 22 | Jerome Benedict Durso | Buy | 12,500 | $4.13 | +$52K | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug